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Abstract 
Traumatic spinal cord injury has major 
effects on the injured person. In case of 
acute complete traumatic spinal cord injury 
methylprednisolone is a standard treatment 
option and surgery is often necessary, but 
these are not a cure for a complete spinal 
cord injury. This paper analyses the 
treatment outcomes in 37 cases of complete 
traumatic spinal cord injuries of which 
some patients received usual treatment and 
some patients received cerebrolysin, as 
neuroprotection and a protocol of 
intravenous fluids to ensure the spinal cord 
perfusion pressure augmentation, and 
standard surgical treatment. 
Key words: neuroprotection, paraplegia, 
spinal cord injury.  
Introduction 
Spinal cord injury can occur at any age, 
can lead to paraplegia or quadriplegia and 
many young people are affected. When a 
spinal trauma occurs there are two types of 
lesions associated with a spinal cord injury: 
a complete spinal cord injury and an 
incomplete spinal cord injury. In complete 
spinal cord injury the normal human spinal 
cord is disrupted. Sandrine Thuret et al 
showed that spinal cord injury can result 
from contusion, compression, penetration 
or maceration of the spinal cord. Spinal 
cord lesion consists of injury of the 
neurons, blood vessels injury, bleeding in 
the central grey matter, spinal cord edema 
and hypoperfusion of the spinal cord and 
the dura mater injury. After the acute spinal 
cord injury, damage to nerve cells and 
fibers and to supporting cells within the 
spinal cord continues to progress for several 
days, perhaps even weeks and it is the 
secondary damage. Spinal cord injury leads 
to the death of nervous cells and the 
interruption of the descending and 
ascending axonal tracts. Spinal cord injury 
culminates in glial scarring and the scar is 
often oriented perpendicular to the neuraxis 
and appears impenetrable. The scar 
contains secreted molecular inhibitors of 
axon growth.  
The immediate surgical treatment must 
remove the tissues causing spinal cord 
compression, must correct a gross 
misalignment and must stabilize the spine. 
During the delayed secondary spinal cord 
injury the early treatment may reduce the 
extent of disability. The secondary spinal 
cord injury is the damage that continues in 
the hours following trauma and consists of  
reduction in blood flow at the level of 
injury, excessive release of 
neurotransmitters (glutamate), inflamatory 
response, free radicals attack neurons and 
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neuronal apoptosis. During this delayed 
secondary spinal cord injury the treatment 
may reduce the extent of disability,  eg. 
methylprednisolone given within 8 hours 
of the injury occuring significantly 
improves recovery in humans (NASCIS  
trials I, II and III).  After a complete spinal 
cord injury there are two types of lesions: 
complete disruption of the spinal cord or 
different types of scars.  
The aim of the present study was to 
assess clinical outcome in a recent serie of 
patients, to analyse whether there is a 
difference in outcome with regard to the 
standard treatment including 
methylprednisolone versus the same type of 
surgical treatment and nonsteroidal anti-
inflammatory drugs and to compare the 
results. 
Methods  
Thirty-seven patients of complete 
traumatic spinal cord injuries were enrolled 
in this study. 
This study included patients with 
complete acute traumatic spinal cord injury 
admitted within 24  hours of injury with a 
complete  neurological evaluations and with  
CT and /or magnetic resonance imaging 
before surgery.  In a period of  9 months 
from a total of 262 patients with traumatic 
spinal cord injuries were 37 patients with 
complete traumatic spinal cord injuries: A 
and B score on ASIA scale.  There were 
nine patients with complete cervical injuries 
with tetraplegia, three patients with dorsal 
(D5-D7) spinal cord injuries with 
paraplegia and 25 patients with dorso-
lumbar (D11-L1) spinal cord injuries with 
paraplegia. Thirty-two patients received 
usual treatment: methylprednisolone and 
surgery for decompression, to realign and 
to stabilize the spine and five patients (only 
A score on ASIA scale) received 
cerebrolysin and a protocol of intravenous 
fluids to ensure the spinal cord perfusion 
pressure augmentation. The five patients 
group consisted of: two cervical spinal cord 
injuries, one of medium dorsal spinal cord 
injury and two patients with dorso-lumbar 
spinal cord injuries. 
Surgical procedure consisted of spinal 
cord decompression and then to realign and 
to stabilize the spine. 
Results  
Concerning the thirty-two patients with 
complete chronic spinal cord injury no 
significant motor  or sensory improvements 
were observed immediate and three to six 
months afterwards. The five patients group 
receiving additional therapy presented in 
evolution a sensory improvements, but no 
significant motor improvements. Three 
patients  in this group of five patients: one 
with thoracal and two dorso-lumbar 
complete spinal cord injuries received 
cerebrolysin one to three months 
postoperatively and the results for these  
three patient were the partial sensory 
recovery  including the sensations of touch, 
pressure, vibration and pain: from A toB 
score on ASIA scale. 
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Figure 1  A, B, C  
Fracture and dislocation of lower cervical spine ( C6-C7) with spinal cord injury ( cervical spine MRI) 
 
Discussion 
Patients with acute traumatic complete 
spinal cord injuries with paraplegia or 
tetraplegia have  a complete disruption of 
the spinal cord, an extensive contusion or 
an extensive hematoma with secondary 
spinal cord injury and late maceration of the 
spinal cord.  
Patients with a complete spinal cord 
injury have an infinitesimal chance of 
recovery. 
The surgical treatment (ideally - within 
eight hours of the injury occuring) must 
remove the tissues causing spinal cord 
compression, must correct a gross 
misalignment and must stabilize the spine.  
Therefore immediate surgery for spinal 
cord decompression including the 
duraplasty, is of high importance for the 
prognosis and evolution of spinal cord 
injury. Various therapies have been applied 
that may be neuroprotective when 
administered soon after injury.  Some of 
these therapies are approaches used  for 
other health purposes but have also shown 
potential in animals with experimental SCI. 
Niklas Marklund in an excellent recent 
material about the spinal cord regeneration 
said that “the current treatment options for 
patients with SCI are limited and the 
neurosurgeon is crucial in the initial 
management, including the medical 
stabilization and the timing of the surgical 
treatment.”Also he showed that „initial 
prehospital management of SCI should 
follow the ATLS principles including 
stabilization, airway management and blood 
pressure control. 
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Figure 2 A, B 
C5  cervical spina fracture with traumatic acute spinal cord hemorrhage, tetraplegia 
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Improved patient management and 
lower morbidity and mortality following 
acute SCI in specialized centers has 
repeatedly been demonstrated and it is 
plausible that the same holds true for 
intensive care unit monitoring and 
aggressive medical management of 
secondary insults.” “Methylprednisolone is 
not standard of care anymore, öptional”at 
best, although could still be considered in 
view of the lack of other treatment 
options”. 
The current recommendation is to treat 
all patients with SCI according to the local 
protocol. If steroids are recommended, they 
should be initiated within 8 hours of injury 
with the following steroid protocol: 
methylprednisolone 30 mg/kg bolus over 15 
minutes and an infusion of 
methylprednisolone at 5.4 mg/kg/h for 23 
hours beginning 45 minutes after the bolus. 
Other drugs with therapeutic potential  
in acute spinal cord injury are: 
- GM-1 ganglioside (Sygen ) decreases 
injury-induced, over-release of damage-
perpetuating excitatory substances. 
- Erytropoietin has neuroprotective 
effects and contributes to neurons 
regeneration 
- neotrofin stimulates growth-factor 
production, enhances proliferation of CNS 
stem cells, and protects neurons from the 
release of excitatory substances. 
- minocycline promotes functional 
recovery, enhances axonal survival, and 
reduces injury-site lesion size etc. 
After passage of  acute and subacute 
stages the patient has a chronic traumatic 
spinal cord injury with complete paraplegia 
or complete tetraplegia; he  has one of two 
types of lesions: complete disruption of the 
spinal cord or different types of scars. The 
complete disruption of the spinal cord is 
the interrupting of the continuity of spinal 
cord without of therapy until now. 
The scar of the spinal cord can be:  
- a complete and impenetrable glial scar 
on the site of spinal cord injury, 
- an incomplete scar and a post-
traumatic syringomyelia or cysts on the site 
of SCI 
- a filiform connective scar of the two 
segments of damaged spinal cord. 
The glial scar is a major impediment to 
axonal regeneration following injury there 
is an  inability to repair spinal cord damage. 
Therefore the first steps in the 
management of SCI can assure an efficient 
treatment in order to minimize the  direct 
traumatic effects on the spinal cord and to 
block the  evolution and progression of the 
secondary spinal cord injury. 
In addition of the standard surgical 
treatment and with or without 
methylprednisolone, we tryed to give for 
some patients: cerebrolysin and a protocol 
of intravenous fluids to ensure the spinal 
cord perfusion pressure augmentation. The 
group of thirty-two patients with complete 
chronic spinal cord injury had no 
significant motor  or sensory improvements 
immediate and three to six months 
afterwards. The five patients group 
receiving additional therapy presented in 
evolution a sensory improvements, but no 
significant motor improvements: from A to 
B score on ASIA scale. 
This is a preliminary study of a 
combination of cerebrolysin and of 
intravenous fluids to ensure the spinal cord 
perfusion pressure augmentation in 
complete traumatic acute spinal cord injury 
and there are few cases with modest results 
but promising, compared to the lack of any 
effective therapeutic alternative. 
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Conclusion 
Initial prehospital management of 
traumatic acute spinal cord injury is crucial 
for the 
morbidity and mortality following acute 
SCI. This study show that cerebrolysin as 
immediate neuroprotective therapy and 
ensuring the spinal cord perfusion pressure 
augmentation has no complications and the 
results are promising, but much follow-up 
work is needed to document the long-term 
benefits. 
This study about treatments in acute 
traumatic spinal cord injury is the subject of 
the grant: “Immediate neuroprotective 
therapy in acute traumatic spinal cord 
injury”, that won the 2011 national 
competition of National Research Council 
(CNCS), Ideas, grant number: PN-II-ID-
PCE-2011-3-0569, funded by CNCS – 
UEFISCDI Romania. 
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